Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
51 studies found for:    " June 02, 2010":" July 02, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" June 02, 2010":" July 02, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed
Has Results
Biobehavioral Interventions for HIV-negative, Stimulant Using Men Who Have Sex With Men
Conditions: HIV Seroconversion;   Stimulant Abuse
Intervention: Drug: Truvada
2 Unknown  Complementary & Alternative Medicine Use in HIV+ Latinos in the US-Mexico Border
Condition: HIV Positive
Intervention:
3 Active, not recruiting RETRIeVE: ReversE TranscRiptase Inhibitor hiV Practice
Condition: HIV Positive
Intervention:
4 Completed Safety and Efficacy of Famciclovir in HIV1 Positive Adults With Recurrent Genital Herpes
Conditions: HIV Positive;   Herpes Simplex, Genital
Intervention:
5 Completed A Pivotal Study to Assess the Safety and Efficacy of The PrePex System, a Male Circumcision Device and Methodology for Rapid Scale up of Painless and Bloodless National Circumcision Programs, in Urban and Remote Rural Settings
Conditions: Male Circumcision;   HIV Prevention;   HIV Infections
Intervention: Device: The PrePex a novel device for adult male circumcision
6 Recruiting Evaluating Methods to Increase HIV Testing, Access to HIV Care, and HIV Prevention Strategies
Condition: HIV Infection
Interventions: Behavioral: Linkage-to-Care Component: Financial Incentive (FI);   Behavioral: Linkage-to-Care Component: Standard of Care (SOC);   Behavioral: Viral Suppression Component: FI;   Behavioral: Viral Suppression Component: SOC;   Behavioral: Prevention for Positives Component: Counseling and SOC;   Behavioral: Prevention for Positives Component: SOC
7 Completed Safety and Pharmacokinetic Trial in Healthy HIV-Negative Women to Assess the Delivery of Dapivirine From a Vaginal Ring
Condition: HIV Infections
Interventions: Drug: dapivirine;   Drug: placebo
8 Unknown  Comparative Effectiveness of Web-based Versus Traditional Adolescent HIV Prevention
Conditions: HIV Infections;   Hepatitis;   Sexually Transmitted Infections
Interventions: Behavioral: Traditional Prevention;   Behavioral: Web-based Prevention
9 Completed Pharmacokinetics of Low Dose Raltegravir
Condition: HIV Infections
Intervention: Drug: raltegravir
10 Unknown  Tenofovir Renal Toxicity and Glomerular Filtration Rate (GFR) Validation
Conditions: Renal Function;   HIV Infection
Intervention: Other: Tc99mDTPA renal clearance
11 Completed Protective Efficacy Against Tuberculosis (TB) Disease, Safety, and Immunogenicity of MVA85A/AERAS-485 in HIV-Infected Adults (C-030-485)
Conditions: Tuberculosis;   HIV Infections
Interventions: Biological: MVA85A/AERAS-485;   Biological: Candida albicans Skin Test Antigen
12 Completed Metabolic and Psychological Changes Associated With Menopause Among Women With HIV
Conditions: HIV Infections;   Menopause
Intervention:
13 Completed
Has Results
Clinical Study of TUTI-16 in HIV-1 Infected and Uninfected Subjects
Condition: HIV Infections
Interventions: Biological: TUTI-16 (0.2mg);   Biological: TUTI-16 (1.0 mg)
14 Unknown  Therapeutic Drug Monitoring (TDM) in Generic Tenofovir/Lamivudine/Efavirenz
Condition: HIV Infections
Intervention: Drug: generic FDC of TDF/3TC/EFV
15 Unknown  Pharmacokinetics (PK) and Safety of 2 Different Doses of Lopinavir/Ritonavir in in HIV/Tuberculosis (TB) Co-infected Patients Receiving Rifampicin Containing Anti-tuberculosis Therapy
Conditions: HIV Infections;   Tuberculosis
Intervention: Drug: LPV/r
16 Not yet recruiting Hepatic Safety of Raltegravir Versus Efavirenz as HIV Therapy for Patients With HIV and HCV Coinfection
Conditions: Hepatitis C, Chronic;   HIV Infection
Interventions: Drug: Raltegravir;   Drug: Efavirenz
17 Unknown  Safety of and Immunogenicity to an H1N1 Influenza Vaccine in HIV-infected Adults
Condition: HIV Infection
Intervention: Biological: Adjuvanted vaccine against H1N1 influenza virus (GSK)
18 Unknown  Study of Cell Phone SMS Messages for Prevention of Maternal to Child Transmission of HIV
Condition: HIV Infections
Intervention: Behavioral: cell phone sms text messaging
19 Completed Novel Measures and Theory of Pediatric Antiretroviral Therapy Adherence in Uganda
Condition: HIV-infection/Aids
Intervention:
20 Completed The Immunogenicity of Varicella-zoster Virus Vaccine in HIV-infected Children
Conditions: HIV Infections;   Varicella-Zoster Virus
Intervention: Biological: VZV vaccination

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years